Phenprocoumon: International drug information (concise)
For abbreviations, symbols, and age group definitions used in Lexicomp (
show table)
International Brand Names
International Brand Names by CountryFor country code abbreviations (
show table)
-
(AE) United Arab Emirates: Marcoumar;
-
(AT) Austria: Marcoumar | Phenprolys;
-
(BE) Belgium: Marcoumar;
-
(BR) Brazil: Marcoumar;
-
(CH) Switzerland: Marcoumar;
-
(DE) Germany: Falithrom | Marcoumar | Marcumar | Marcuphen | Phenpro | Phenprocoumon acis | Phenprogamma;
-
(FI) Finland: Marcoumar;
-
(FR) France: Marcoumar;
-
(GB) United Kingdom: Marcoumar;
-
(LT) Lithuania: Marcoumar | Marcumar;
-
(LU) Luxembourg: Marcoumar;
-
(LV) Latvia: Marcumar;
-
(NL) Netherlands: Fenprocoumon | Fenprocoumon ratiopharm | Marcoumar;
-
(NO) Norway: Marcoumar | Phenprogamma;
-
(PL) Poland: Marcumar;
-
(TR) Turkey: Marcoumar;
-
(UY) Uruguay: Marcoumar
Index Terms
- Fenprocumone;
- Phenprocoumarol;
- Phenprocoumarole;
- Phenprocoumone;
- Phenprocumone
Pharmacologic Category
-
Anticoagulant, Coumarin Derivative;
-
Vitamin K Antagonist
Reported Use
Treatment of thromboembolic disorders.
Dosage Range
Adults: Oral: Usual dose: 6 to 9 mg once on day 1, followed by 6 mg on day 2; beginning on day 3: 1.5 to 4.5 mg once daily depending on achievement of target INR.
Product Availability
Product available in various countries; not currently available in the US
Dosage Forms
Tablet, Oral: 3 mg
Topic 16450 Version 32.0